We are live on ! Find out more
RCI

Ridgeback Capital Investments Portfolio holdings

AUM $560K
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$24.6M
AUM Growth
Cap. Flow
+$20.1M
Cap. Flow %
82.01%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$14M
2
AFMD
Affimed
AFMD
+$6.17M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCYC
1
Bicycle Therapeutics
BCYC
$269M
$15.3M 62.17%
+844,235
New +$14M
AFMD
2
DELISTED
Affimed
AFMD
$9.29M 37.83%
+1,485,898
New +$6.17M

Similar funds

Ridgeback Capital Investments's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Ridgeback Capital Investments, which disclosed 2 positions worth $24.6M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Bicycle Therapeutics: 844,235 shares worth $15.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ridgeback Capital Investments's largest Q4 2023 buy was Bicycle Therapeutics: 844,235 shares worth $15.3M.
  • Ridgeback Capital Investments's ten largest holdings make up 100% of its $24.6M portfolio in Q4 2023.
  • Ridgeback Capital Investments disclosed 2 positions in Q4 2023, its first 13F filing on record.

Based on Ridgeback Capital Investments's 13F filing for Q4 2023, filed 14 Feb 2024.